Bristol Myers Unites R&D Organization Under Cristian Massacesi
Bristol Myers Squibb said Cristian Massacesi, currently its executive vice president, chief medical officer and head of development, will lead the unified organization.
Related stories
AAON Expands Credit Facility to Up to $1.2 Billion
AAON said it refinanced and expanded its credit facility to up to $1.2 billion.
M impact | EQUITY | Nov 12, 2026, 03:11 PM UTC
Hyperliquid Nvidia Perpetual Futures Reach Nearly $2 Billion in 24-Hour Volume
The Nvidia-linked contract ranked second on Hyperliquid, behind Bitcoin perpetual futures.
M impact | EQUITY | Nov 12, 2026, 03:10 PM UTC
Page Industries Shares Plunge 13% as Higher Raw-Material Costs Hit Q2 Profitability
Page Industries shares fell 13% to Rs. 31,850, their lowest level since April, as investors reacted to second-quarter profitability pressure from higher raw-material costs.
M impact | EQUITY | Nov 12, 2026, 03:09 PM UTC
Maersk Opens Montevideo Logistics Facility With Investment Above USD 20 Million
Maersk opened a logistics facility in Montevideo, investing more than USD 20 million.
M impact | EQUITY | Nov 12, 2026, 03:07 PM UTC
US Neocloud Stocks Fall Up to 16% After Huang Resigns as Nvidia CEO
Nebius led losses in early US trading as investors assessed the implications of Jensen Huang's resignation from Nvidia.
M impact | EQUITY | Nov 12, 2026, 03:06 PM UTC
Southern Company Announces $1.75 Billion Mandatory Convertible
Southern Company announced a $1.75 billion mandatory convertible. Its shares edged down.
M impact | EQUITY | Nov 12, 2026, 03:05 PM UTC